Journal Article
Uchegbu IF, Double JA, Kelland LR, Turton JA, Florence AT.  1996.  The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models.. J Drug Target. 3(5):399-409.
Uchegbu IF, Florence AT.  1996.  Adverse drug events related to dosage forms and delivery systems.. Drug Saf. 14(1):39-67.
Lalatsa A, Schätzlein AG, Mazza M, Le TBich Hang, Uchegbu IF.  2012.  Amphiphilic poly(L-amino acids) - new materials for drug delivery.. J Control Release. 161(2):523-36.
Dufès C, Muller J-M, Couet W, Olivier J-C, Uchegbu IF, Schätzlein AG.  2004.  Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles.. Pharm Res. 21(1):101-7.
Uchegbu IF.  2005.  Applying advanced delivery technologies to enable and improve drug development. 8-9 December 2004, London, UK.. IDrugs. 8(2):112-4.
Mazza M, Uchegbu IF, Schätzlein AG.  2008.  Cancer and the blood-brain barrier: 'Trojan horses' for courses? Br J Pharmacol. 155(2):149-51.
Chisholm EJ, Vassaux G, Martin-Duque P, Chevre R, Lambert O, Pitard B, Merron A, Weeks M, Burnet J, Peerlinck I et al..  2009.  Cancer-specific transgene expression mediated by systemic injection of nanoparticles.. Cancer Res. 69(6):2655-62.
Qu X, Khutoryanskiy VV, Stewart A, Rahman S, Papahadjopoulos-Sternberg B, Dufès C, McCarthy D, Wilson CG, Lyons R, Carter KC et al..  2006.  Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude.. Biomacromolecules. 7(12):3452-9.
Lalatsa A, Schätzlein AG, Garrett NL, Moger J, Briggs M, Godfrey L, Iannitelli A, Freeman J, Uchegbu IF.  2015.  Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.. J Control Release. 197:87-96.
Chooi KWai, Hou XLiang, Qu X, Soundararajan R, Uchegbu IF.  2013.  Claw amphiphiles with a dendrimer core: nanoparticle stability and drug encapsulation are directly proportional to the number of digits.. Langmuir. 29(13):4214-24.
Thompson CJ, Tetley L, Uchegbu IF, Cheng WP.  2009.  The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery.. Int J Pharm. 376(1-2):46-55.
Schätzlein AG.  2006.  Delivering cancer stem cell therapies - a role for nanomedicines? Eur J Cancer. 42(9):1309-15.
Lalatsa A, Garrett NL, Ferrarelli T, Moger J, Schätzlein AG, Uchegbu IF.  2012.  Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Mol Pharm. 9(6):1764-74.
Dufès C, Uchegbu IF, Schätzlein AG.  2005.  Dendrimers in gene delivery.. Adv Drug Deliv Rev. 57(15):2177-202.
Cassano R, Ferrarelli T, Schätzlein AG, Uchegbu IF, Trombino S.  2013.  Dextran-pegylated microparticles for enhanced cellular uptake of hydrophobic drugs.. Eur J Pharm Biopharm. 84(3):540-8.
Uchegbu IF, Double JA, Turton JA, Florence AT.  1995.  Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse.. Pharm Res. 12(7):1019-24.
Uchegbu IF, Turton JA, Double JA, Florence AT.  1994.  Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouse.. Biopharm Drug Dispos. 15(8):691-707.
Uchegbu IF.  2004.  Drug transport and drug delivery--the Midnight Sun meeting.. IDrugs. 7(8):743-5.
Dimitrijevic D, Lamandin C, Uchegbu IF, Shaw AJ, Florence AT.  1997.  The effect of monomers and of micellar and vesicular forms of non-ionic surfactants (Solulan C24 and Solulan 16) on Caco-2 cell monolayers.. J Pharm Pharmacol. 49(6):611-6.
Arunothayanun P, Bernard MS, Craig DQ, Uchegbu IF, Florence AT.  2000.  The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether.. Int J Pharm. 201(1):7-14.
Brucoli F, Natoli A, Marimuthu P, Borrello MTeresa, Stapleton P, Gibbons S, Schätzlein A.  2012.  Efficient synthesis and biological evaluation of proximicins A, B and C.. Bioorg Med Chem. 20(6):2019-24.
Sludden J, Uchegbu IF, Schätzlein AG.  2000.  The encapsulation of bleomycin within chitosan based polymeric vesicles does not alter its biodistribution.. J Pharm Pharmacol. 52(4):377-82.
Siew A, Le H, Thiovolet M, Gellert P, Schätzlein A, Uchegbu I.  2012.  Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Mol Pharm. 9(1):14-28.
Hollins AJ, Benboubetra M, Omidi Y, Zinselmeyer BH, Schätzlein AG, Uchegbu IF, Akhtar S.  2004.  Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor.. Pharm Res. 21(3):458-66.
Garrett NLaura, Lalatsa A, Uchegbu I, Schätzlein A, Moger J.  2012.  Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy.. J Biophotonics. 5(5-6):458-68.